Investments (Tables)

12 Months Ended

Dec. 31, 2024

Investments, Debt and Equity Securities [Abstract]

Schedule of Investments

The carrying values of the Company's investments, by category, were as follows (in millions):

Date	Equity Method (1)		Fair Value (2)		Measurement Alternative (3)		Total
December 31, 2024	$	0.9	$	1.8	$	0.9	$	3.6
December 31, 2023	$	0.9	$	—	$	0.9	$	1.8

(1) The Company's equity method investments as of both December 31, 2024 and 2023, were comprised of MediBeacon and Scaled Cell.

(2) The Company's fair value investment in common stock of a publicly traded company was purchased during the year ended December 31, 2024.

(3) The Company's measurement alternative method investment as of both December 31, 2024 and 2023, was comprised of Triple Ring.